These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 27890419)
1. In vitro activity of tigecycline alone and antimicrobial combinations against clinical Neisseria gonorrhoeae isolates. Lee H; Kim H; Seo YH; Yong D; Jeong SH; Lee K; Chong Y Diagn Microbiol Infect Dis; 2017 Feb; 87(2):160-162. PubMed ID: 27890419 [TBL] [Abstract][Full Text] [Related]
2. In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae. Furuya R; Koga Y; Irie S; Ikeda F; Kanayama A; Kobayashi I; Tanaka M J Infect Chemother; 2013 Dec; 19(6):1218-20. PubMed ID: 23564350 [TBL] [Abstract][Full Text] [Related]
3. Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution. Wind CM; de Vries HJ; van Dam AP Int J Antimicrob Agents; 2015 Mar; 45(3):305-8. PubMed ID: 25532741 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates. Hauser C; Hirzberger L; Unemo M; Furrer H; Endimiani A Antimicrob Agents Chemother; 2015 Mar; 59(3):1605-11. PubMed ID: 25547354 [TBL] [Abstract][Full Text] [Related]
5. Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731 [TBL] [Abstract][Full Text] [Related]
6. Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics. Liang JY; Cao WL; Li XD; Bi C; Yang RD; Liang YH; Li P; Ye XD; Chen XX; Zhang XB BMC Infect Dis; 2016 Apr; 16():152. PubMed ID: 27080231 [TBL] [Abstract][Full Text] [Related]
7. Twenty-five-year changing pattern of gonococcal antimicrobial susceptibility in Shanghai: surveillance and its impact on treatment guidelines. Gu WM; Chen Y; Yang Y; Wu L; Hu WZ; Jin YL BMC Infect Dis; 2014 Dec; 14():731. PubMed ID: 25547132 [TBL] [Abstract][Full Text] [Related]
8. In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era. Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R PLoS One; 2018; 13(3):e0193678. PubMed ID: 29509792 [TBL] [Abstract][Full Text] [Related]
9. Combination therapy for gonorrhoea: in vitro synergy testing. Pereira R; Cole MJ; Ison CA J Antimicrob Chemother; 2013 Mar; 68(3):640-3. PubMed ID: 23152483 [TBL] [Abstract][Full Text] [Related]
10. Comparison of E-test with agar dilution methods in testing susceptibility of N. gonorrhoeae to azithromycin. Yasin RM; Suan KA; Meng CY Sex Transm Dis; 1997 May; 24(5):257-60. PubMed ID: 9153733 [TBL] [Abstract][Full Text] [Related]
11. Surveillance of the Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Collected in Changsha, China from 2003 to 2015. Peng T; Lin H; Liu Q; Yang J; Cao W; Ding H; Tang L Jpn J Infect Dis; 2017 Sep; 70(5):518-521. PubMed ID: 28367885 [TBL] [Abstract][Full Text] [Related]
12. In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae. Bharat A; Martin I; Zhanel GG; Mulvey MR J Infect Chemother; 2016 Mar; 22(3):194-7. PubMed ID: 26603424 [TBL] [Abstract][Full Text] [Related]
13. In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae. Barbee LA; Soge OO; Holmes KK; Golden MR J Antimicrob Chemother; 2014 Jun; 69(6):1572-8. PubMed ID: 24468865 [TBL] [Abstract][Full Text] [Related]
14. Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China. Yuan LF; Yin YP; Dai XQ; Pearline RV; Xiang Z; Unemo M; Chen XS Sex Transm Dis; 2011 Aug; 38(8):764-8. PubMed ID: 21844727 [TBL] [Abstract][Full Text] [Related]
15. Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006. Lee H; Hong SG; Soe Y; Yong D; Jeong SH; Lee K; Chong Y Sex Transm Dis; 2011 Nov; 38(11):1082-6. PubMed ID: 21992988 [TBL] [Abstract][Full Text] [Related]
16. In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae. Furuya R; Nakayama H; Kanayama A; Saika T; Iyoda T; Tatewaki M; Matsuzaki K; Kobayashi I; Tanaka M J Infect Chemother; 2006 Aug; 12(4):172-6. PubMed ID: 16944253 [TBL] [Abstract][Full Text] [Related]
17. In Vitro Synergy Testing of Gentamicin, an Old Drug Suggested as Future Treatment Option for Gonorrhoea, in Combination With Six Other Antimicrobials Against Multidrug-Resistant Neisseria gonorrhoeae Strains. Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R Sex Transm Dis; 2018 Feb; 45(2):127-131. PubMed ID: 28876284 [TBL] [Abstract][Full Text] [Related]
18. In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains. Jacobsson S; Golparian D; Phan LT; Ohnishi M; Fredlund H; Or YS; Unemo M J Antimicrob Chemother; 2015 Jan; 70(1):173-7. PubMed ID: 25182063 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam. Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520 [TBL] [Abstract][Full Text] [Related]
20. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae. Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]